Novel survey disseminated through Twitter supports its utility for networking, disseminating research, advocacy, clinical practice and other professional goals

Por Borgmann, Hendrik, DeWitt, Sasha, Tsaur, Igor, Haferkamp, Axel, Loeb, Stacy
Publicado no Can Urol Assoc J (2015)

SARS-CoV-2 outbreak in medical employees in a large urologic department: Spread, containment and outcome

Por Brandt, Maximilian Peter, Jäger, Wolfgang, Epple, Stefan, Haferkamp, Axel, Schröder, Annette
Publicado no Am J Infect Control (2021)

The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma

Por Weissinger, Daniel, Tagscherer, Katrin E, Macher-Göppinger, Stephan, Haferkamp, Axel, Wagener, Nina, Roth, Wilfried
Publicado em 2013

Protein profile of basal prostate epithelial progenitor cells—stage‐specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivo

Por Höfner, Thomas, Klein, Corinna, Eisen, Christian, Rigo‐Watermeier, Teresa, Haferkamp, Axel, Sprick, Martin R.
Publicado no J Cell Mol Med (2016)

Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology

Por Borgmann, Hendrik, Höfner, Thomas, Sasca, Daniel, Porubsky, Stefan, Tsaur, Igor, Haferkamp, Axel, Dotzauer, Robert
Publicado no Eur Urol (2021)

Valproate inhibits colon cancer growth through cell cycle modification in vivo and in vitro

Por STREY, CHRISTOPH W., SCHAMELL, LEA, OPPERMANN, ELSIE, HAFERKAMP, AXEL, BECHSTEIN, WOLF O., BLAHETA, ROMAN A.
Publicado em 2011

Publication of Original Research in Urologic Journals – A Neglected Orphan?

Por Mani, Jens, Makarević, Jasmina, Juengel, Eva, Ackermann, Hanns, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2012

Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo

Por Juengel, Eva, Makarević, Jasmina, Tsaur, Igor, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2013

Utilization of surgical safety checklists by urological surgeons in Germany: a nationwide prospective survey

Por Borgmann, Hendrik, Helbig, Sarah, Reiter, Michael A., Hüsch, Tanja, Schilling, David, Tsaur, Igor, Haferkamp, Axel
Publicado no Patient Saf Surg (2015)

Detection of early DJ-stent encrustation by sonographic twinkling-artifacts – a pilot study

Por Blaheta, Roman A., Oertl, Anton, Freisleben, Hans-Joachim, Nelson, Karen, Ackermann, Hanns, Haferkamp, Axel, Engl, Tobias
Publicado no Cent European J Urol (2017)

I Publish in I Edit? - Do Editorial Board Members of Urologic Journals Preferentially Publish Their Own Scientific Work?

Por Mani, Jens, Makarević, Jasmina, Juengel, Eva, Ackermann, Hanns, Nelson, Karen, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2013

Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism()()...

Por Juengel, Eva, Makarević, Jasmina, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2014

Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

Por Juengel, Eva, Kim, Dana, Makarević, Jasmina, Reiter, Michael, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A
Publicado no J Cell Mol Med (2015)

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

Por Thomas, Christian, Bartsch, Georg, Walter, Christian, Borgmann, Hendrik, Brandt, Maximilian Peter, Höfner, Thomas, Haferkamp, Axel, Tsaur, Igor
Publicado no Dent J (Basel) (2016)

PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target

Por Erb, Holger Hans Hermann, Ebert, Marlies, Kuhn, Ronja, Donix, Lukas, Haferkamp, Axel, Seed, Robert Ian, Jüngel, Eva
Publicado no PLoS One (2019)

Qualitative Twitter analysis of participants, tweet strategies, and tweet content at a major urologic conference

Por Borgmann, Hendrik, Woelm, Jan-Henning, Merseburger, Axel, Nestler, Tim, Salem, Johannes, Brandt, Maximilian P., Haferkamp, Axel, Loeb, Stacy
Publicado no Can Urol Assoc J (2016)

Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections Decrease

Por Borgmann, Hendrik, Boehm, Katharina, Brandt, Maximilian Peter, Kamal, Mohammed M., Mager, Rene, Höfner, Thomas, Tsaur, Igor, Haferkamp, Axel
Publicado no Urol Int (2021)

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2

Por Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Kaulfuss, Silke, Reiter, Michael, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2014

Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells

Por Makarević, Jasmina, Tawanaie, Nassim, Juengel, Eva, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A
Publicado em 2014

Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro

Por Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Kaulfuss, Silke, Tsaur, Igor, Nelson, Karen, Pfitzenmaier, Jesco, Haferkamp, Axel, Blaheta, Roman A.
Publicado em 2014